Millions of people take metformin, a Type 2 diabetes medication that lowers blood sugar. The "wonder drug" has also been shown to slow cancer growth, improve COVID outcomes and reduce inflammation.

Recent research from Stanford University and Harvard Medical School (both MA, USA) has used a combination of mouse models, human blood samples and statistical analysis to reveal the mechanism behind ...

Though Ozempic launched into the pop culture lexicon in late 2022, the drug, once known for its catchy commercial jingle, achieved Food & Drug Administration approval for A1C management in 2017.

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

Before the explosive popularity of GLP-1 weight loss drugs, another "wonder drug," metformin, has been at work lowering blood sugar levels for patients with Type 2 diabetes for decades, but scientists ...

Please provide your email address to receive an email when new articles are posted on . Metformin lowered the risk for long COVID in adults with overweight or obesity across several analyses. More ...

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type 1 diabetes, opening doors for improved management of the condition. For ...

Discover more about how a common diabetes drug can reduce the incidence of intermediate age-related macular degeneration.